Attribute | Details |
---|---|
Brand Name | Silvitra |
Active Ingredients | Sildenafil 100 mg, Vardenafil 20 mg |
Form | Tablet |
Mechanism | PDE5 Inhibition |
Indications | Erectile Dysfunction |
Storage | Store at room temperature |
Overdose Symptoms | Nausea, dizziness, chest pain |
Visit for More Information |
Mechanism of Action
The pharmaceutical agent Silvitra combines two active ingredients, sildenafil 100 mg and vardenafil 20 mg. These compounds act as potent phosphodiesterase type 5 (PDE5) inhibitors. The dual mechanism works by blocking the PDE5 enzyme in the smooth muscle of the corpus cavernosum. The inhibition of this enzyme leads to an increased level of cyclic guanosine monophosphate (cGMP). Elevated cGMP levels promote muscle relaxation and blood vessel dilation, crucial for achieving and maintaining an erection. This unique combination allows for improved blood flow, which is vital for erectile function.
Indications for Use
Silvitra is primarily indicated for the treatment of erectile dysfunction (ED) in men. This condition, characterized by the inability to achieve or maintain an erection, can have various underlying causes, including vascular, psychological, or hormonal factors. Silvitra addresses the vascular component by enhancing blood flow to the penile region. Clinical studies support its efficacy, indicating a significant improvement in erectile function in men treated with this combination therapy. It’s recommended for individuals who do not respond adequately to monotherapy with either sildenafil or vardenafil alone.
Storage Recommendations
Proper storage of Silvitra ensures its efficacy and longevity. Keep the tablets in their original packaging, away from moisture and direct sunlight. Maintain a stable room temperature, ideally between 20°C to 25°C (68°F to 77°F). Do not store it in a bathroom or near a sink. Ensure the medication is out of reach of children and pets. Avoid using Silvitra beyond its expiration date, as this could reduce its effectiveness or cause adverse effects.
Recognizing Overdose Symptoms
An overdose of Silvitra can manifest in several alarming symptoms. Users may experience severe nausea, dizziness, or chest pain. Other signs include prolonged erections, also known as priapism, which can result in long-term damage if not treated promptly. In the event of suspected overdose, immediate medical intervention is crucial. Emergency healthcare providers can administer supportive treatments to mitigate adverse effects. Monitoring and careful adherence to prescribed doses reduce overdose risks.
честные казино с быстрыми выплатами
бездепозитные бонусы казино
играть в лучшем казино на деньги
база казино с бездепозитным бонусом
онлайн казино России
casino oyunu
Where to Purchase Silvitra Online
Acquiring Silvitra online necessitates diligence in choosing reputable sources. Several licensed online pharmacies offer authentic Silvitra, ensuring safety and quality. Verify the pharmacy’s credentials and customer reviews before purchase. Be cautious of websites offering significantly lower prices, as they may distribute counterfeit products. Consulting healthcare professionals can guide patients to legitimate online sources. For more scientific details, consult resources like NCBI.
Source:
- https://www.911mg.org/erectile-dysfunction/zudena.htm
- https://axy7.com/bv-bacterial-vaginosis-and-its-broader-implications/
- https://allergyad.com/2024/01/15/exploring-cinvanti-a-potential-breakthrough-in-fasciolopsiasis-treatmen/
- https://devnamic.co/morphine-tablets-understanding-skyrizi-in-psoriasis-management/
- https://betterlover.com/moxestrol-insights-into-hormonal-pathways-in-reproductive-health/
- https://sumanthapaliya.com/2024/03/07/chlorothalidone-a-key-player-in-hypertension-control/
- https://delagua.com.co/efectos-de-la-benzatina-en-las-atrofias-opticas-hereditarias-estudios-recientes/
- https://pptakmirulislam.com/neuromyelitis-optica-meneliti-kemajuan-terapi/
- https://terrycher.ad-wize.net/arthritis-and-contraceptive-interventions/
- https://webuildpathways.com/tangier-disease-and-dermatological-advances/